Is Creatine for Everyone? A Complete Guide to Who Benefits, Who Should Wait, and What the Evidence Says

Creatine monohydrate is not for everyone, but it is appropriate for most healthy adults who exercise. It is a widely used, well-studied sports nutrition supplement, not an FDA-approved drug, and the FDA does not evaluate dietary supplements for efficacy before they reach the market. In people with normal kidney function, the supplement literature spanning several decades has not established a pattern of organ damage at typical doses. The exceptions that matter are people with existing kidney disease, people on drugs that stress the kidneys, young children, and the rare individuals with inherited disorders of creatine metabolism. For those groups, a conversation with a physician should come before a bottle of powder.
What creatine is, and what it is not
Creatine is a compound the body makes from the amino acids arginine, glycine, and methionine, mostly in the liver and kidneys. About 95% of the body's creatine is stored in skeletal muscle as phosphocreatine, which helps regenerate ATP during short, maximal bursts of effort like a heavy lift or a sprint. Food, mainly red meat and fish, supplies some dietary creatine; supplementation adds to what the body already produces and what the diet provides.
Creatine monohydrate is a dietary supplement in the United States, regulated under a different framework than prescription drugs. It is not a controlled substance and is not banned by WADA, the NCAA, or other major sporting bodies. It should not be confused with anabolic steroids, which have a different mechanism and a different regulatory and safety profile entirely.
Several branded variants exist, including creatine hydrochloride, buffered creatine (marketed as Kre-Alkalyn), creatine ethyl ester, and creatine nitrate. Head-to-head comparisons in the sports nutrition literature have generally not shown these forms to outperform plain creatine monohydrate on measures of muscle creatine content or strength outcomes, and monohydrate remains the least expensive and most extensively studied option. Readers considering an alternative form because of marketing claims of "better absorption" or "no bloating" should treat those claims skeptically until an independent comparative trial is checked.
Who the evidence supports most clearly
The strongest and most consistent evidence sits with people doing resistance or high-intensity interval training. Multiple systematic reviews summarized by the International Society of Sports Nutrition's position statement on creatine describe measurable improvements in strength and repeated high-intensity effort compared with placebo in trained and untrained adults. Team-sport athletes with repeated sprint demands (soccer, basketball, rugby) tend to see functional benefit; pure endurance athletes see less direct performance benefit, though creatine may support glycogen recovery between sessions.
Adults over roughly 50 are a population where the case for creatine extends past athletic performance. Several meta-analyses of resistance training combined with creatine in older adults report a meaningful edge in lean tissue mass over resistance training alone. Preserving muscle mass in this age group is tied to lower fall risk and better functional independence, which is why this is one of the more clinically relevant creatine findings, not just a performance one. Specific numeric estimates for the size of that lean-mass advantage vary between reviews and should be confirmed against the primary meta-analysis before being repeated as an exact figure.
Women are underrepresented in creatine trials relative to men, but the studies that exist show comparable phosphocreatine loading and comparable relative strength gains. There is no evidence that normal hormonal fluctuation blunts the response. This is a case where absence of large trial numbers is a genuine evidence gap, not evidence of an absent effect.
Vegetarians and vegans, who get little or no dietary creatine from food, tend to start with lower muscle and possibly lower brain creatine stores. Several trials suggest this group may see a larger relative response to supplementation on both performance and cognitive measures than habitual meat eaters, because they are moving further from a lower baseline. This is a plausible and reasonably supported pattern, not a guarantee for any individual.
Who should check with a clinician before starting
Chronic kidney disease. Creatine supplementation raises serum creatinine, the marker used to estimate kidney filtration. In people with normal kidneys this rise reflects increased creatine turnover, not kidney injury, and reviews of long-term creatine use in healthy people have not found evidence of renal harm. That reassurance does not extend to people who already have reduced kidney function, polycystic kidney disease, or a single functioning kidney. In compromised kidneys, added metabolic and filtration load is a legitimate concern, and supplementation should not start without a nephrologist's input.
People on nephrotoxic medications. Chronic high-dose NSAID use, certain chemotherapy agents, and calcineurin inhibitors such as tacrolimus or cyclosporine can already stress kidney clearance. Adding creatine on top of these drugs can make a rising serum creatinine harder to interpret, potentially masking a real decline in kidney function behind an expected supplement-related bump.
Children under 12. Professional pediatric guidance has generally not endorsed creatine supplementation in prepubescent children, primarily because long-term safety data in this age group is thin, not because a specific harm has been documented. Adolescents aged roughly 12 to 18 have appeared in some trials without reported adverse effects, but supplementation in this group should involve a parent and a physician, and dosing should not be self-directed.
Rare inherited metabolic disorders. Creatine transporter deficiency (SLC6A8 mutations) and guanidinoacetate methyltransferase (GAMT) deficiency are rare inborn errors of creatine metabolism, usually identified in childhood, in which normal supplementation does not behave as expected and may not be appropriate outside specialist management.
Anyone with an unexplained or unmonitored kidney function abnormality. If a routine blood panel already shows an elevated creatinine of unknown cause, that should be worked up before adding a supplement that predictably raises the same number.
Dosing patterns commonly used in the research
Two dosing approaches show up repeatedly in trials. A "loading" protocol uses roughly 20 grams a day, split into several smaller doses, for about a week, followed by a lower daily maintenance dose. A slower approach uses a steady 3 to 5 grams a day from the start, reaching similar muscle saturation over roughly a month instead of a week. Neither approach has shown a durable performance advantage over the other once saturation is reached; loading simply gets there faster and is more likely to cause temporary bloating or loose stools because of the larger single doses.
Body size is a reasonable factor to weigh: some sports nutrition guidance suggests slightly higher maintenance doses for larger individuals and slightly lower doses for smaller ones, though this is a general pattern rather than a precise formula. Timing relative to a workout appears to matter far less than taking it consistently every day. None of this substitutes for individualized guidance from a treating clinician, especially for anyone in one of the caution groups above.
What creatine does and does not do for the brain
The brain uses a large share of the body's energy relative to its size and depends on the same phosphocreatine system as muscle for rapid ATP regeneration. This has motivated research into cognitive effects, and a handful of small randomized trials have reported improvements in short-term memory or reasoning tasks, with the clearest signal appearing under conditions of sleep deprivation or mental fatigue rather than in well-rested subjects. Vegetarians, who tend to have lower baseline brain creatine, have shown larger relative improvements in some of these trials than habitual meat eaters.
This is a genuinely promising but early area. The trials are small, the outcome measures vary between studies, and the effect under normal rested conditions is much less clear than the effect under stress or sleep loss. Interest in creatine's role in age-related cognitive decline and neurodegenerative disease is active in the research community, but it remains investigational. Readers should not treat cognitive benefit as an established, general-population effect the way high-intensity exercise performance is established.
Common claims worth checking against the evidence
"Creatine causes hair loss." This idea traces back to a single small study reporting a hormonal ratio change in a group of rugby players, a finding that has not been consistently replicated in larger analyses of testosterone and dihydrotestosterone with creatine use. The claim is not well supported, but a single unreplicated study should not be treated as fully closed either.
"Creatine causes dehydration or cramping." Observational data from athletic programs has generally not shown higher cramping or heat-illness rates in creatine users compared with non-users. Creatine increases water retention inside muscle cells, which is a fluid-shift effect, not dehydration. This is reassuring but comes from observational rather than tightly controlled experimental data, so it describes an association, not a proven mechanism ruling out all individual reactions.
"Creatine is a steroid." It is not. It has a different chemical structure, a different mechanism, and a different regulatory classification than anabolic steroids.
"You need to cycle on and off creatine." There is no established physiological reason the body needs a break from creatine. Stopping simply lets muscle stores decline back toward baseline over several weeks; there is no known withdrawal effect requiring a scheduled break.
"Creatine is only useful for young male athletes." The research in older adults, women, and vegetarians argues against this. It is a supplement with the most trial data in young athletic men, which is a statement about who has been studied, not a statement about who can benefit.
Quotations attributed to named creatine researchers in earlier drafts of consumer content on this topic could not be independently verified against a citable, dated source for this rewrite and have been removed rather than repeated.
Side effects in context
The most consistently reported effects in healthy adults are mild: modest water-weight gain (roughly 1 to a few pounds) in the first week or two from increased intracellular water, and gastrointestinal discomfort during rapid loading with large single doses, which is largely avoidable by using the slower 3 to 5 gram daily approach instead.
Long-term observational follow-up of athletes using creatine for extended periods has generally not shown adverse changes in kidney function, liver enzymes, or blood lipids in healthy people. This reassurance is specific to people who started with normal organ function; it does not extend to people with pre-existing disease, who were excluded or underrepresented in that kind of long-term athlete data.
One practical point clinicians should know: creatine use raises serum creatinine on standard blood panels. If you are having kidney function checked while taking creatine, tell the ordering clinician, since a cystatin C-based estimate of kidney function is less affected by creatine intake than the standard creatinine-based calculation.
What is established, what is plausible, and what is not established
Established: Creatine monohydrate increases muscle phosphocreatine stores and improves measures of high-intensity exercise capacity in healthy adults across a substantial body of randomized trial evidence. In people with normal kidney function, typical supplemental doses have not been shown to cause kidney damage in available long-term data.
Plausible but not settled: A meaningful cognitive benefit under conditions like sleep deprivation or mental fatigue, a larger relative benefit in vegetarians and older adults, and a role in supporting bone density when combined with resistance training. These have supportive smaller trials but need larger, more consistent replication before being treated as settled clinical facts.
Not established: Any benefit or harm profile in children under 12, in people with existing kidney disease, or in people with inherited creatine metabolism disorders. Any claim that a specific branded or "advanced" form of creatine outperforms monohydrate for a typical healthy adult.
A decision framework: should you take it, or check with a doctor first?
Use this as a starting filter, not a diagnosis. It is meant to organize the decision, not replace a clinician's judgment.
| Your situation | What the evidence suggests | Reasonable next step |
|---|---|---|
| Healthy adult, no kidney disease, doing resistance or high-intensity training | Best-supported group; likely benefit for strength and training capacity | Standard maintenance dosing discussed with a knowledgeable provider or trainer; no medical clearance typically required |
| Adult over 50, otherwise healthy, doing or starting resistance training | Reasonably strong evidence for added lean-mass benefit alongside training | Same as above; pair with a structured resistance program, since creatine without training shows a much smaller effect |
| Vegetarian or vegan | Plausible larger relative benefit due to lower baseline stores | Reasonable candidate; still confirm no kidney or other contraindication first |
| Woman of any age, healthy | Limited trial volume but consistent relative benefit where studied | Reasonable candidate; understand the evidence base is smaller than for men |
| Adolescent (12 to 18) in organized sport | Some trial data, no clear red flags, but data is limited | Only with a parent and physician involved, not self-directed |
| Child under 12 | Data insufficient | Do not supplement outside a documented clinical reason and physician supervision |
| Known chronic kidney disease, polycystic kidney disease, or single kidney | Added metabolic and filtration load is a real theoretical risk | Do not start without nephrologist clearance |
| On nephrotoxic medication (certain NSAID regimens, calcineurin inhibitors, some chemotherapy) | Interpreting kidney labs becomes harder; risk of masking true decline | Discuss with prescribing physician before adding creatine |
| Known or suspected inherited creatine metabolism disorder (SLC6A8, GAMT) | Standard supplementation logic may not apply | Manage only under specialist care |
| Recent unexplained abnormal kidney labs | Creatine will complicate interpretation of future labs | Resolve the abnormality first; mention creatine use to your clinician if already taking it |
If more than one row applies to you, the more restrictive row should govern your next step.
Choosing a product
Look for third-party testing seals such as NSF Certified for Sport, Informed Sport, or USP Verified, which confirm label accuracy and screen for banned substances, particularly relevant for competitive athletes. Creatine monohydrate manufactured under the Creapure name (produced by AlzChem in Germany) is a widely used, well-characterized raw material that many supplement brands license, and checking for it on an ingredient panel is a reasonable quality signal, though it is not the only acceptable source.
Avoid products that bundle creatine into a proprietary blend with unlisted stimulant or herbal doses. A plain creatine monohydrate product with a transparent dose per serving is the simplest and best-supported choice for most people.
When to involve a doctor urgently rather than just before starting
Stop supplementation and seek medical attention if you notice a large or rapid weight change, signs of dehydration despite adequate fluid intake, decreased urination, swelling, or new muscle pain that seems disproportionate to training, since these could indicate an unrelated medical issue that a supplement history alone will not explain. Routine blood work changes (an isolated bump in creatinine) in someone taking creatine are expected and usually not a cause for alarm on their own, but any abnormal kidney panel should still be discussed with a clinician rather than assumed to be caused by the supplement.
Frequently asked questions
Is creatine safe for everyone?
Does creatine damage the kidneys?
How much creatine should I take?
Does creatine cause hair loss?
Is creatine useful for women?
Should older adults consider creatine?
Does creatine help brain function?
Do you need to cycle creatine?
Is creatine monohydrate better than other forms like HCl or buffered creatine?
Can teenagers take creatine?
A note on the evidence in this article
Creatine is among the most heavily studied supplements in sports nutrition, but many popular articles on the topic repeat precise numbers (exact percentage gains, exact kilogram figures, named quotations) without a checkable citation. This rewrite has deliberately used more general language for those claims and flags them as needing verification against the primary trial or systematic review before being restated as exact figures in a published version. Readers who want the underlying literature can search the National Library of Medicine's database directly.
Further reading
- PubMed search: creatine supplementation, general search of the primary literature; individual results should be evaluated for study design and population before drawing conclusions
- ClinicalTrials.gov search: creatine, ongoing and completed trials involving creatine supplementation
